ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Program

Four-factor Prothrombin Complex Concentrate

Also written as “BE1116”, “Beriplex® P/N (Kcentra)” and “4-Factor Prothrombin Complex Concentrate (4F-PCC)”.

Its studies are mostly in Wounds and Injuries · Hemophilia B · Blood Coagulation Disorders, led by 2 companies.

Drug pageFour-factor Prothrombin Complex Concentrate: every studyAll 9 studies of it, academic ones too, with its approvals, label and forms.
Furthest: phase 3, since Jul 1, 20085 company-led studies, 1 open or runningNext primary completion: Apr 6, 2027 (phase 3)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
CSL41 open or runningphase 3since Jul 1, 2008Jul 1, 2008Apr 6, 2027phase 3 · NCT07094087
Johnson & Johnsonits history only10 open or runningphase 1since Jul 28, 2020Jul 28, 2020none ahead

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and studies of CSL only; the figures above count every company.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Jul 1, 2008First study: phase 3 study in Blood Coagulation DisordersFirst studyNCT00708435 · 216 enrolled · United States, Belarus, Bulgaria and more
  2. Dec 4, 2008Phase 3 study in Hemophilia BNCT00803101 · 176 enrolled · United States, Belarus, Bulgaria and more
  3. Oct 3, 2022Phase 3 study in Wounds and InjuriesNCT05568888 · 1,366 enrolled · United States, Australia, United Kingdom
  4. Jul 14, 2025Phase 3 study in Complex Cardiovascular Surgery With Cardiopulmonary BypassNCT07094087 · 200 planned · United States, Canada, Japan and more

Ahead

  1. Apr 6, 2027Primary completion: phase 3 study in Complex Cardiovascular Surgery With Cardiopulmonary BypassNCT07094087

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 4 CSL leads, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07094087Complex Cardiovascular Surgery With Cardiopulmonary Bypass · United States, Canada, Japan and more3RecruitingApr 6, 2027200
NCT05568888Wounds and Injuries · United States, Australia, United Kingdom3TerminatedOct 29, 20241,366
NCT00803101Hemophilia B · United States, Belarus, Bulgaria and more3CompletedNov 2012176
NCT00708435Blood Coagulation Disorders · United States, Belarus, Bulgaria and more3CompletedNov 2010216

How it is read

Names in the registry

  • “BE1116”, 2 entries
  • “Beriplex® P/N (Kcentra)”, 2 entries
  • “4-Factor Prothrombin Complex Concentrate (4F-PCC)”, 1 entry

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.